PKM2 and HSPA5 were significantly increased in high-risk endometrial cancer, regarding low-risk endometrial cancer and normal endometrium, suggesting they are potentially predicting risk biomarkers for endometrial cancer [43]. This evidence concerns the gene PKM and endometrial cancer.